PILL Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL seeks to deliver investment results of 3x the daily performance of the S&P Pharmaceuticals Select Industry Index, a modified equal-weighted index that measures the performance of pharmaceutical companies, as defined by GICS, on the S&P Total Market Index. The fund uses derivatives and swaps to achieve its target exposure. As a levered product with daily resets, PILL is designed as a short-term trading tool and not a long-term investment vehicle. As a result, long-term returns could materially differ from those of the underlying index due to daily compounding. Prior to August 2, 2019, the fund aimed to provide 3x leveraged exposure to the Dynamic Pharmaceutical Intellidex Index. Effective February 27, 2026, the fund replaced the term Shares in its name with ETF.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| PILL | +14.7% | -26.1% | +27.9% | +73.7% | +46.4% | -4.9% |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$52K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| RAPP RAPPORT THERAPEUTICS INC | 0.16% | $22.0M | $4.5M |
| ALMS ALUMIS INC | 0.19% | $10.7M | $1.0M |
| RLMD RELMADA THERAPEUTICS INC | 0.16% | $1.7M | $0 |
| ELAN ELANCO ANIMAL HEALTH INC | 0.32% | $1.0M | $100K |
| AQST AQUESTIVE THERAPEUTICS INC | 0.13% | $99K | $379K |
| EYPT EYEPOINT INC | 0.01% | $52K | $0 |
| LXRX LEXICON PHARMACEUTICALS INC | 0.12% | $50K | $0 |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | PILL SPSIPH SWAP ASSET LEG (SPSIPHBCL) | 29.22% |
| 2 | XERS XERIS BIOPHARMA HOLDINGS INC | 0.61% |
| 3 | MANE VERADERMICS INC | 0.45% |
| 4 | MAZE MAZE THERAPEUTICS INC | 0.38% |
| 5 | LLY ELI LILLY & CO | 0.36% |
| 6 | VTRS VIATRIS INC | 0.36% |
| 7 | PCRX PACIRA BIOSCIENCES INC | 0.36% |
| 8 | AMRX AMNEAL PHARMACEUTICALS INC | 0.36% |
| 9 | SEPN SEPTERNA INC | 0.34% |
| 10 | ETON ETON PHARMACEUTICALS INC | 0.33% |
| 11 | RPRX ROYALTY PHARMA PLC- CL A | 0.33% |
| 12 | PRGO PERRIGO CO PLC | 0.33% |
| 13 | ZTS ZOETIS INC | 0.32% |
| 14 | ELAN ELANCO ANIMAL HEALTH INC | 0.32% |
| 15 | LGND LIGAND PHARMACEUTICALS | 0.31% |
| 16 | EWTX EDGEWISE THERAPEUTICS INC | 0.31% |
| 17 | PFE PFIZER INC | 0.30% |
| 18 | JNJ JOHNSON & JOHNSON | 0.30% |
| 19 | COLL COLLEGIUM PHARMACEUTICAL INC | 0.29% |
| 20 | JAZZ JAZZ PHARMACEUTICALS PLC | 0.29% |
| 21 | OGN ORGANON & CO | 0.29% |
| 22 | ANIP ANI PHARMACEUTICALS INC | 0.29% |
| 23 | MRK MERCK & CO. INC. | 0.28% |
| 24 | AMLX AMYLYX PHARMACEUTICALS INC | 0.28% |
| 25 | BMY BRISTOL-MYERS SQUIBB CO | 0.28% |
| 26 | OMER OMEROS CORP | 0.27% |
| 27 | TARS TARSUS PHARMACEUTICALS INC | 0.26% |
| 28 | MBX MBX BIOSCIENCES INC | 0.26% |
| 29 | DFTX DEFINIUM THERAPEUTICS INC | 0.26% |
| 30 | PBH PRESTIGE CONSUMER HEALTHCARE | 0.26% |
| 31 | INVA INNOVIVA INC | 0.25% |
| 32 | ELVN ENLIVEN THERAPEUTICS INC | 0.25% |
| 33 | TRVI TREVI THERAPEUTICS INC | 0.25% |
| 34 | AMPH AMPHASTAR PHARMACEUTICALS IN | 0.24% |
| 35 | SUPN SUPERNUS INC | 0.24% |
| 36 | ZVRA ZEVRA THERAPEUTICS INC | 0.24% |
| 37 | HRMY HARMONY BIOSCIENCES HOLDINGS | 0.23% |
| 38 | LBRX LB PHARMACEUTICALS INC | 0.23% |
| 39 | LQDA LIQUIDIA CORP | 0.23% |
| 40 | HROW HARROW INC | 0.22% |
| 41 | ANRO ALTO NEUROSCIENCE INC | 0.21% |
| 42 | AXSM AXSOME THERAPEUTICS INC | 0.20% |
| 43 | ALMS ALUMIS INC | 0.19% |
| 44 | NUVB NUVATION BIO INC | 0.19% |
| 45 | CORT CORCEPT THERAPEUTICS INC | 0.18% |
| 46 | WVE WAVE LIFE SCIENCES INC | 0.18% |
| 47 | OCUL OCULAR THERAPEUTIX INC | 0.16% |
| 48 | PAHC PHIBRO ANIMAL HEALTH CORP-A | 0.16% |
| 49 | RAPP RAPPORT THERAPEUTICS INC | 0.16% |
| 50 | RLMD RELMADA THERAPEUTICS INC | 0.16% |
| 51 | PHAT PHATHOM PHARMACEUTICALS INC | 0.14% |
| 52 | ACRS ACLARIS THERAPEUTICS INC | 0.14% |
| 53 | AVLN AVALYN PHARMA INC | 0.13% |
| 54 | AQST AQUESTIVE THERAPEUTICS INC | 0.13% |
| 55 | CRMD CORMEDIX INC | 0.12% |
| 56 | LXRX LEXICON PHARMACEUTICALS INC | 0.12% |
| 57 | ARVN ARVINAS INC | 0.10% |
| 58 | EOLS EVOLUS INC | 0.10% |
| 59 | BIOA BIOAGE LABS INC | 0.08% |
| 60 | CTNM CONTINEUM THERAPEUTICS INC-A | 0.07% |
| 61 | EYPT EYEPOINT INC | 0.01% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Sep 22, 2026 | $0.0009 |
| Jun 23, 2026 | $0.0152 |
| Mar 24, 2026 | $0.0109 |
| Dec 23, 2025 | $0.0326 |
| Sep 23, 2025 | $0.0098 |
| Jun 24, 2025 | $0.0245 |
| Mar 25, 2025 | $0.0183 |
| Dec 23, 2024 | $0.0131 |
| Sep 24, 2024 | $0.0287 |
| Jun 25, 2024 | $0.0219 |
| Mar 19, 2024 | $0.0272 |
| Dec 21, 2023 | $0.0382 |
| Sep 19, 2023 | $0.0353 |
| Jun 21, 2023 | $0.0492 |
| Mar 21, 2023 | $0.0191 |
| Dec 20, 2022 | $0.0317 |
| Sep 20, 2022 | $0.0167 |
| Jun 22, 2022 | $0.0036 |
| Mar 22, 2022 | $0.0082 |
| Dec 21, 2021 | $0.0001 |
| Dec 23, 2019 | $0.0003 |
| Sep 24, 2019 | $0.0152 |
| Jun 25, 2019 | $0.0224 |
| Mar 19, 2019 | $0.0573 |
| Dec 27, 2018 | $0.0986 |
| Sep 25, 2018 | $0.0434 |
| Jun 19, 2018 | $0.0523 |
| Dec 19, 2017 | $0.0135 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in PILL in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error